![Michelle Gilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Gilson
Direktor/Vorstandsmitglied bei
RANI THERAPEUTICS HOLDINGS, INC.
Vermögen: - $ am 30.06.2026
Profil
Michelle Gilson is currently Director at Rani Therapeutics Holdings, Inc. since 2026.
Formerly, Ms. Gilson was Chief Financial Officer at Arcellx, Inc. from 2022 to 2026, Analyst at Canaccord Genuity LLC from 2018 to 2022, Analyst at Canaccord Genuity, Inc. in 2018, Equity Associate at Jefferies LLC from 2017 to 2018, Associate Director at Oppenheimer & Co., Inc. (Broker) from 2015 to 2016, Analyst at Goldman Sachs & Co. LLC in 2014, and Research Analyst at Instinet LLC.
Ms. Gilson completed undergraduate studies at USC Marshall School of Business in 2014.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.08.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Michelle Gilson
| Unternehmen | Position | Beginn |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 01.08.2026 |
Ehemalige bekannte Positionen von Michelle Gilson
| Unternehmen | Position | Ende |
|---|---|---|
| ARCELLX, INC. | Finanzdirektor/CFO | 28.04.2026 |
Canaccord Genuity LLC
 Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.05.2022 |
Canaccord Genuity, Inc.
 Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 21.03.2018 |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.03.2018 |
Oppenheimer & Co., Inc. (Broker)
 Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.11.2016 |
Ausbildung von Michelle Gilson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Instinet LLC
 Instinet LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
USC Marshall School of Business
 USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Genuity, Inc.
Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
